Thursday, June 1, 2023

Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Pvt. Ltd.), a global values-based, R&D-driven biopharmaceutical leader, has been recognized as a Top Employer by the Top Employers Institute for the third consecutive year.  Takeda was also certified as the global Top Employer for 2023, making it the sixth consecutive year in a row for Takeda globally.

Additionally, Takeda has been recognized as a top employer across 22 countries strengthening its commitment to creating a diverse, equitable, and inclusive working environment and an exceptional employee experience. Takeda is among 15 companies worldwide to receive global certification for the year 2023.  

On being a recipient of the Top Employer certification 2023, Ms Serina Fischer, General Manager, Takeda Biopharmaceuticals India Private Limited said, “We are delighted to have been named as the Top Employer for the third consecutive year. This accolade by the Top Employers Institute® is reflective of our people practices benchmarked against the best in the industry. We strive to create a working environment where our teams feel valued, and respected and are empowered to make a meaningful difference in the lives of patients. We are committed to providing our employees with the support, resources, and opportunities they need to grow and excel in their careers, and we will continue to work towards maintaining our position as a top employer in the pharmaceutical industry.”  

Mr. Anoop Kamat, Head of Human Resources, Takeda Biopharmaceuticals India Private Limited added, “We are committed to fostering a culture of collaboration, diversity, equity, and inclusion to create exceptional employee experiences. Our participation in the Top Employer certification also helps us evaluate our people practices and provides insights into our strengths and opportunities for continual improvement. We are proud of this achievement and remain committed to creating a culture that enables success for the excellent talent we have at Takeda.”